Ascletis Pharma Inc. (ASCLF)
USD 0.62
(0.0%)
USD 0.62
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -126.09 Million CNY | 16.15% |
| 2022 | -284.49 Million CNY | -39.84% |
| 2021 | -169.34 Million CNY | -28.69% |
| 2020 | -181.94 Million CNY | -804.46% |
| 2019 | -73.63 Million CNY | 70.79% |
| 2018 | -48.93 Million CNY | 21.29% |
| 2017 | -61.63 Million CNY | -60.5% |
| 2016 | -40.27 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - CNY | 16.15% |
| 2023 Q4 | -29.96 Million USD | 0.0% |
| 2023 Q2 | -10.3 Million USD | 0.0% |
| 2022 FY | - CNY | -39.84% |
| 2022 Q2 | -16.58 Million USD | 0.0% |
| 2022 Q4 | -29.53 Million USD | 0.0% |
| 2021 Q2 | -14.4 Million USD | 0.0% |
| 2021 Q4 | -16.01 Million USD | 0.0% |
| 2021 FY | - CNY | -28.69% |
| 2020 FY | - CNY | -804.46% |
| 2020 Q2 | -9.26 Million USD | 0.0% |
| 2020 Q4 | -18.36 Million USD | 0.0% |
| 2019 Q4 | -8.34 Million USD | 0.0% |
| 2019 FY | - CNY | 70.79% |
| 2019 Q2 | -10.43 Million USD | 0.0% |
| 2018 Q2 | 10.94 Million CNY | -32.24% |
| 2018 FY | - CNY | 21.29% |
| 2018 Q1 | 16.15 Million CNY | 0.0% |
| 2017 Q2 | -17.06 Million CNY | -1868.17% |
| 2017 FY | - CNY | -60.5% |
| 2017 Q1 | -867 Thousand CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 234.085% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -19838.299% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 24006.544% |
| Qrons Inc. | -40.08 Thousand USD | -314490.454% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -13357.616% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -625.912% |
| BioStem Technologies, Inc. | -7.55 Million USD | -1569.274% |
| Skye Bioscience, Inc. | -13.54 Million USD | -830.729% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -34236.544% |
| Rebus Holdings, Inc. | -951 Thousand USD | -13158.78% |
| CSL Limited | 4.78 Billion USD | 102.633% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -127.852% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -7105.204% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -694.537% |
| Adynxx, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -3146.154% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -77.503% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -2026.715% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -52624.65% |
| SQZ Biotechnologies Company | -64.14 Million USD | -96.584% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -4668.141% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -8108.788% |
| Mesoblast Limited | -62.38 Million USD | -102.102% |
| Marizyme, Inc. | -34.28 Million USD | -267.811% |
| Genus plc | 73.7 Million USD | 271.087% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -1807.142% |
| Pharming Group N.V. | 9.87 Million USD | 1376.612% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -8377.207% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -3454.865% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -1337.426% |
| ContraFect Corporation | -64.99 Million USD | -93.989% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -2685.806% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -8894.884% |
| IMV Inc. | -35.52 Million USD | -254.952% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -5326.023% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -24239.73% |
| ONE Bio Corp. | 13.61 Million USD | 1026.251% |
| Accustem Sciences Inc. | -3.74 Million USD | -3265.641% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -161.453% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -9850.897% |
| Q BioMed Inc. | -617.62 Thousand USD | -20315.363% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 3629.983% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -5419.44% |
| Biomind Labs Inc. | -1.03 Million USD | -12088.016% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -218.116% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -4259.502% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -1660.734% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 1875337.954% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -504264.0% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -4939.685% |
| GB Sciences, Inc. | -1.41 Million USD | -8780.367% |
| Alpha Cognition Inc. | -9.7 Million USD | -1199.157% |
| HST Global, Inc. | -5303.00 USD | -2377629.587% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -6029.849% |
| Halberd Corporation | -74.27 Thousand USD | -169653.228% |
| Enzolytics Inc. | -2.12 Million USD | -5842.002% |
| Agentix Corp. | -1.37 Million USD | -9091.941% |
| Resverlogix Corp. | -11.74 Million USD | -973.846% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -4016.564% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -216.02 Million USD | 41.631% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 10460.805% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 1524.145% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -8312.202% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 33383.093% |
| AVAX Technologies, Inc. | -6.11 Million USD | -1962.79% |
| Zenith Capital Corp. | -8.6 Million USD | -1365.152% |
| Genscript Biotech Corporation | -248.71 Million USD | 49.304% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -723687.383% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -5054.016% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -71532.699% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -6464.125% |
| Kadimastem Ltd | -2.62 Million USD | -4704.6% |
| Helix BioMedix, Inc. | -1.04 Million USD | -11950.994% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -69529.683% |
| LadRx Corporation | 412.28 Thousand USD | 30683.604% |
| Cell Source, Inc. | -4.27 Million USD | -2851.205% |
| Regen BioPharma, Inc. | 1.46 Million USD | 8701.281% |
| NovAccess Global Inc. | -1.03 Million USD | -12085.095% |
| Affymax, Inc. | -14.29 Million USD | -782.064% |
| Itoco Inc. | -1.86 Million USD | -6646.46% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -33115.057% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -11198.477% |
| Mobile Lads Corp. | -2.24 Million USD | -5526.151% |
| CytoDyn Inc. | -18.02 Million USD | -599.379% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -159450.292% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -1030981.855% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -25861.851% |
| SYBLEU INC | -141.57 Thousand USD | -88965.557% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -11772.864% |
| International Stem Cell Corporation | 202 Thousand USD | 62521.287% |
| Bioxytran, Inc. | -3.82 Million USD | -3200.685% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -239434.574% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -5021.628% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -251.532% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -280102.222% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -4505.223% |
| Neutra Corp. | -181.24 Thousand USD | -69468.6% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -525.482% |
| PureTech Health plc | -11.62 Million USD | -984.467% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -525.525% |
| IXICO plc | -707 Thousand USD | -17734.653% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -1540.742% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -160.81% |
| CSL Limited | 4.73 Billion USD | 102.664% |
| Cellectis S.A. | -92.63 Million USD | -36.114% |